Labcorp deploys targeted sequencing for SARS-CoV-2

June 23, 2021

Molecular Loop Biosciences, a company focused on targeted sequencing, announced that its SARS-CoV-2 Research Sequencing Panel has been deployed by Labcorp to help sequence thousands of complete coronavirus genomes each week from positive patient samples.

This sequencing is being performed as part of a U.S. Centers for Disease Control and Prevention (CDC) effort to identify and track the spread of SARS-CoV-2 variants throughout the country, Molecular Loop Biosciences said.

The Molecular Loop SARS-CoV-2 Research Sequencing Panel converts extracted RNA samples into sequencer-ready libraries in four steps. Redundant probe tiling technology allows for the detection of emerging variants while alleviating the concern of amplicon or allele dropouts that can occur in amplicon-based workflows.

Visit Molecular Loop for more news